Marie Stenmark Askmalm

Summary

Affiliation: University Hospital
Country: Sweden

Publications

  1. ncbi request reprint Mutation and accumulation of p53 related to results of adjuvant therapy of postmenopausal breast cancer patients
    Marie Stenmark Askmalm
    Department of Biomedicine and Surgery, Division of Oncology, Faculty of Health, Sciences, Linkoping University, Linkoping, Sweden
    Acta Oncol 43:235-44. 2004
  2. ncbi request reprint Altered expression of cyclin E and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancer
    Marie Ahnström Waltersson
    Linkoping University, Faculty of Health Sciences, Department of Clinical and Experimental Medicine, KEF oncology laboratory, University Hospital, SE 581 85 Linkoping, Sweden
    Int J Oncol 34:441-8. 2009
  3. ncbi request reprint p53 polymorphic variants at codon 72 and the outcome of therapy in randomized breast cancer patients
    Pia Wegman
    Division of Cell Biology, Department of Biomedicine and Surgery, Faculty of Health Sciences, 581 85 Linkoping, Sweden
    Pharmacogenet Genomics 16:347-51. 2006
  4. ncbi request reprint Intact Mre11/Rad50/Nbs1 complex predicts good response to radiotherapy in early breast cancer
    Karin Söderlund
    Department of Biomedicine and Surgery, Division of Oncology, Linkoping University, Linkoping, Sweden
    Int J Radiat Oncol Biol Phys 68:50-8. 2007
  5. doi request reprint Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy
    Patrik Johansson
    Department of Clinical and Experimental Medicine, Linkoping University, Sweden
    Acta Oncol 48:504-13. 2009
  6. ncbi request reprint The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer
    Karin Söderlund
    Department of Biomedicine and Surgery, Linkoping University, Linkoping, Sweden
    Radiother Oncol 84:242-51. 2007
  7. ncbi request reprint Low expression of Ku70/80, but high expression of DNA-PKcs, predict good response to radiotherapy in early breast cancer
    Karin Söderlund Leifler
    Department of Clinical and Experimental Medicine, Division of Surgery and Clinical Oncology, Linkoping University, Linkoping, Sweden
    Int J Oncol 37:1547-54. 2010

Collaborators

  • Karin Söderlund
  • Charlotta Dabrosin
  • Lars E Rutqvist
  • Bo Nordenskjold
  • Pia Wegman
  • Barbro Linderholm
  • O Stal
  • Karin Söderlund Leifler
  • Tommy Fornander
  • Marie Ahnström Waltersson
  • Patrik Johansson
  • Siv Queseth
  • Rune Gustavsson
  • Helena Fohlin
  • Peter Skoog
  • Rebecka Malterling
  • Claes Klintenberg
  • Lambert Skoog
  • Lars Gunnar Arnesson
  • Göran Tejler
  • Ann Rundcrantz
  • Eibert Einarsson
  • Hans Starkhammar
  • Monika Dufmats
  • Susanne Vahlin
  • Sten Thorstenson
  • Bedrich Vitak
  • Bengt Norberg
  • Måns Agrup
  • Bengt Asking
  • Marie Sundquist
  • Harald Bång
  • Tord Blomkvist
  • Kerstin Nordenskjöld
  • Annika Malmström

Detail Information

Publications7

  1. ncbi request reprint Mutation and accumulation of p53 related to results of adjuvant therapy of postmenopausal breast cancer patients
    Marie Stenmark Askmalm
    Department of Biomedicine and Surgery, Division of Oncology, Faculty of Health, Sciences, Linkoping University, Linkoping, Sweden
    Acta Oncol 43:235-44. 2004
    ..Finally, altered p53 status is probably not a marker of resistance to tamoxifen...
  2. ncbi request reprint Altered expression of cyclin E and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancer
    Marie Ahnström Waltersson
    Linkoping University, Faculty of Health Sciences, Department of Clinical and Experimental Medicine, KEF oncology laboratory, University Hospital, SE 581 85 Linkoping, Sweden
    Int J Oncol 34:441-8. 2009
    ..17; 95% CI, 0.052-0.58) as compared to patients with either altered Rb or p53 or both (RR=0.70; 95% CI, 0.28-1.73)...
  3. ncbi request reprint p53 polymorphic variants at codon 72 and the outcome of therapy in randomized breast cancer patients
    Pia Wegman
    Division of Cell Biology, Department of Biomedicine and Surgery, Faculty of Health Sciences, 581 85 Linkoping, Sweden
    Pharmacogenet Genomics 16:347-51. 2006
    ..The p53 protein is a key determinant to induce either growth arrest or apoptosis in response to cytotoxic stress...
  4. ncbi request reprint Intact Mre11/Rad50/Nbs1 complex predicts good response to radiotherapy in early breast cancer
    Karin Söderlund
    Department of Biomedicine and Surgery, Division of Oncology, Linkoping University, Linkoping, Sweden
    Int J Radiat Oncol Biol Phys 68:50-8. 2007
    ..To investigate the expression and predictive role of the Mre11/Rad50/Nbs1 (MRN) complex and the ataxia-telangiectasia mutated protein (ATM) for the outcome of radiotherapy in breast cancer patients...
  5. doi request reprint Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy
    Patrik Johansson
    Department of Clinical and Experimental Medicine, Linkoping University, Sweden
    Acta Oncol 48:504-13. 2009
    ..The aim of this study was to compare the clinical outcome of patients with stage I breast cancer diagnosed during two time periods that differed with respect to adjuvant systemic therapy...
  6. ncbi request reprint The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer
    Karin Söderlund
    Department of Biomedicine and Surgery, Linkoping University, Linkoping, Sweden
    Radiother Oncol 84:242-51. 2007
    ..This study evaluates the prognostic and predictive role of BRCA1, BRCA2 and Rad51, individually and as a complex, in breast cancer...
  7. ncbi request reprint Low expression of Ku70/80, but high expression of DNA-PKcs, predict good response to radiotherapy in early breast cancer
    Karin Söderlund Leifler
    Department of Clinical and Experimental Medicine, Division of Surgery and Clinical Oncology, Linkoping University, Linkoping, Sweden
    Int J Oncol 37:1547-54. 2010
    ..We believe that the results reflect the different roles of DNA-PKcs and Ku70/80 in repair and cell death regulation after DNA damage. These differences could be of importance when developing drugs that target DNA repair...